---
title: "US Trends in Cardiovascular Risk Factors and Predicted CVD Risk, 1999–2023"
id: "medrxiv-1-trends-in-cardiovascular-risk-factors-disease-management-and-predicted"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-trends-in-cardiovascular-risk-factors-disease-management-and-predicted"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1?rss=1"
published_at: "2026-11-10T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# US Trends in Cardiovascular Risk Factors and Predicted CVD Risk, 1999–2023
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-trends-in-cardiovascular-risk-factors-disease-management-and-predicted
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1?rss=1)
- **Published At:** 2026-11-10T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators analyzed 11 NHANES survey periods spanning 1999-2000 through 2021-2023 among 60,199 nonpregnant adults aged ≥20 years. The analysis used survey-weighted regression and age-standardized trends. - The team assessed prevalence, awareness, treatment, and control for **hypertension**, **dyslipidemia**, and **diabetes**, and used PREVENT equations to estimate 10- and 30-year predicted risks among adults without self-reported cardiovascular disease. - **Obesity** prevalence rose from 47.4% to 57.2% across the study interval; class III obesity increased from 4.7% to 9.7%. - **Diabetes** prevalence increased from 8.2% to 12.7%. At the same time, current **smoking** declined from 24.4% to 14.9%. - Hypertension, dyslipidemia, chronic kidney disease, and prior CVD did not show statistically significant linear trends in prevalence, though mean systolic **blood pressure** fell (124.2 to 120.2 mm Hg) and mean total cholesterol declined (203.6 to 188.1 mg/dL). - Awareness and treatment for **hypertension** and **dyslipidemia** increased; **LDL** control improved (17.0% to 34.2%). - **Blood pressure** control rose earlier but fell after 2013-2014 (peak control 32.5% in 2013-2014, then down to 21.5% in 2021-2023). - Glycemic control peaked at 51.2% (2003-2004) and declined to 41.9% by 2021-2023; diabetes awareness increased but treatment trends were not significant. - Predicted 10-year total **CVD** risk decreased modestly (5.66% to 5.28%); predicted 10-year ASCVD risk declined modestly while predicted 10-year **heart failure** risk increased (increase of 0.10 per decade). - The authors conclude that improvements in smoking, blood pressure, and lipids coexist with rising obesity and diabetes and divergent predicted ASCVD and HF risks. - Data source, ethics, and analytic details: publicly available NHANES data; NHANES protocols approved by the National Center for Health Statistics Research Ethics Review Board; this article is a preprint and has not been peer reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Sx71XvDQlJa0fLNUL6hRo5Eu0Cw593uxM.Utb3ka3js-1794383920.4898858-1.2.1.1-QS4M8oxxkH9oJ.F.t4n9oXdrFlfVqX_IxV5.hVanr7.ikzc9Lrm4DDt4eTWhmwYi) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Trends in Cardiovascular Risk Factors, Disease Management, and Predicted Cardiovascular Risk Among US Adults, 1999-2023 [ View ORCID Profile](http://orcid.org/0009-0000-3591-3684)Hafiz M Ahmed, Muhammad Owais, Nawal Younas doi: https://doi.org/10.64898/2026.11.09.26367683 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Hafiz M Ahmed 1 Faisalabad Medical University, PAKISTAN; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hafiz%2BM%2BAhmed%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ahmed%20HM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHafiz%2BM%2BAhmed%2B) * [ORCID record for Hafiz M Ahmed](http://orcid.org/0009-0000-3591-3684 "Open in new tab") * For correspondence: mohammadahmed818@yahoo.com Muhammad Owais 1 Faisalabad Medical University, PAKISTAN; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Muhammad%2BOwais%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Owais%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMuhammad%2BOwais%2B) Nawal Younas 2 Allied Hospital Faisalabad, PAKISTAN * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nawal%2BYounas%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Younas%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANawal%2BYounas%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1341715/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1341715/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1341715/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1341715/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1341715/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Cardiovascular risk factors have changed in the United States, but trends in prevalence, management, and predicted risk through the post-pandemic period remain incompletely characterized. Methods: We analyzed 11 National Health and Nutrition Examination Survey (NHANES) periods (1999-2000 through 2021-2023) among 60,199 nonpregnant adults aged 20 years. Survey-weighted regression assessed age-standardized trends, subgroup differences, and measurement-change sensitivity. We assessed awareness, treatment, and control of hypertension, dyslipidemia, and diabetes. PREVENT equations estimated 10- and 30-year risks among adults without self-reported cardiovascular disease (CVD). Results: Obesity increased from 47.4% to 57.2% (odds ratio [OR] per decade, 1.23; 95% CI, 1.16-1.30), with class III obesity more than doubling (4.7% to 9.7%). Diabetes increased from 8.2% to 12.7% (OR, 1.26; 95% CI, 1.19-1.34), while current smoking declined from 24.4% to 14.9% (OR, 0.76; 95% CI, 0.71-0.81). Hypertension, dyslipidemia, chronic kidney disease, and prior CVD showed no significant linear trends, although mean systolic blood pressure (BP) (124.2 to 120.2 mm Hg) and total cholesterol (203.6 to 188.1 mg/dL) declined, alongside improvements in other lipids. Hypertension and dyslipidemia awareness and treatment increased, but BP control peaked at 32.5% in 2013-2014 before declining to 21.5%, while LDL cholesterol control rose from 17.0% to 34.2%. Diabetes awareness increased, but treatment trends were nonsignificant. Glycemic control peaked at 51.2% in 2003-2004 before declining to 41.9% (P for nonlinearity Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.09.26367675v1 "Wealth inequalities in timely postnatal care in Malawi: how much do antenatal care and place of delivery explain?") Posted November 10, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/10/2026.11.09.26367683.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.09.26367683v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/10/2026.11.09.26367683.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Trends in Cardiovascular Risk Factors, Disease Management, and Predicted Cardiovascular Risk Among US Adults, 1999-2023 Hafiz M Ahmed, Muhammad Owais, Nawal Younas medRxiv 2026.11.09.26367683; doi: https://doi.org/10.64898/2026.11.09.26367683 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367683v1%26text%3DTrends%2520in%2520Cardiovascular%2520Risk%2520Factors%252C%2520Disease%2520Management%252C%2520and%2520Predicted%2520Cardiovascular%2520Risk%2520Among%2520US%2520Adults%252C%25201999-2023 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367683v1%26t%3DTrends%2520in%2520Cardiovascular%2520Risk%2520Factors%252C%2520Disease%2520Management%252C%2520and%2520Predicted%2520Cardiovascular%2520Risk%2520Among%2520US%2520Adults%252C%25201999-2023 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367683v1%26title%3DTrends%2520in%2520Cardiovascular%2520Risk%2520Factors%252C%2520Disease%2520Management%252C%2520and%2520Predicted%2520Cardiovascular%2520Risk%2520Among%2520US%2520Adults%252C%25201999-2023%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367683v1%26title%3DTrends%2520in%2520Cardiovascular%2520Risk%2520Factors%252C%2520Disease%2520Management%252C%2520and%2520Predicted%2520Cardiovascular%2520Risk%2520Among%2520US%2520Adults%252C%25201999-2023 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.09.26367683v1&count=horizontal&via=&text=Trends%20in%20Cardiovascular%20Risk%20Factors%2C%20Disease%20Management%2C%20and%20Predicted%20Cardiovascular%20Risk%20Among%20US%20Adults%2C%201999-2023&counturl=www.medrxiv.org/content/10.64898/2026.11.09.26367683v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (919) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5015) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (429) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (679) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1695) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16282) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7289) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5303) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1473) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1836) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16501) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7616) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1132) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1296) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3751) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (466) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (721) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (786) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6149) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10009) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2539) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1524) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1271) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (663) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (805) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (598) * [Surgery](https://www.medrxiv.org/collection/surgery) (806) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (308) Evaluation/discussion of this paper x Comments 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our [Comment Policy](https://connect.medrxiv.org/news/2022/03/21/commenting_on_preprints) before commenting. The content of a comment is not endorsed by medRxiv. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](https://medrxiv.org/alerts). Sign In to Follow this Preprint Email * Email this Articleclose Thank you for your int
## Related Clinical Research

- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Long-term complication profiles after transsphenoidal vs transcranial resection of adult craniopha](https://medichelpline.com/clinical-feed/plos-one-9-long-term-complication-profiles-following-transsphenoidal-and-transcranial.md)
- [CKM Burden Predicts Echocardiographic Recovery and Cardiovascular Events in Hypertension](https://medichelpline.com/clinical-feed/medrxiv-6-impact-of-cardiovascular-kidney-metabolic-burden-on-echocardiographic.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.